Open accessResearch articleFirst published online 2014-4
Predisposing,enabling and need factors of heroin addicts' using prescribed methadone or buprenorphine for a year or longer: An exploratory study of drug treatment for heroin addicts in the Swedish welfare system
This exploratory study draws on national register data for 2,638 opioid users from 2004-2008 to examine whether or not certain predisposing, enabling and need factors are associated with taking methadone or buprenorphine continuously on doctor's orders for one year or more.
Design
Chi-square analysis, one-way Anova and logistic regression methods were used to explore the association between self-reported demographic characteristics, alcohol/drug use severity, substance use disorder treatment history, criminal justice history, level of mental health symptomatology, mental health treatment history, and whether or not adult opioid users had taken methadone or buprenorphine continuously on doctor's orders for one year or longer.
Results
Having a job and having had more voluntary treatment episodes were significantly associated with using methadone or buprenorphine. Those opioid users who had a job were 19 times more likely to be on methadone or buprenorphine than opiate users who did not have a job.
Conclusions
In our study, individuals who were working were significantly more likely to medicate against their opioid abuse. This suggests that they may be more socially integrated than their non-medicating counterparts.
AndersenR. M. (1995). Revisiting the behavioral model and access to medical care: Does it matter?Journal of Health and Social Behavior, 36(3), 1–10.
2.
Armelius,B-Å., NyströmS., EngströmC., & BrännströmJ. (2009). Referensmaterial för bättre använding av ASI intervjun: Slutrapport.Institutet för utveckling av metoder i socialt arbete. Socialstyrelsen (National Board of Health and Welfare). Stockholm, Sweden.
3.
Armelius,B-Å., & ArmeliusK. (2011). En naturalistisk studie av 14000 svenska missbruksklienter baserad på Addiction Severity Index, ASI.Missbruket, Kunskapen, Vården, Missbruksutredningens forskningsbilaga, 6, 97–167.
4.
BurnsL., RandallD., HallW., LawM., ButlerT., BellJ., & DegenhardtL. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention.Addiction, 104(8), 1363–1372.
5.
ChathamL., HillerM., Rowan-SzalG., JoeG., & SimpsonD. (1999). Gender differences at admission and follow-up in a sample of methadone maintenance clients.Substance Use and Misuse, 34(8), 1137–1165.
6.
DavstadI., StenbackaM., LeifmanA., BeckO., KorkmazS., RomelsjöA. (2007). Patterns of illicit drug use and retention in a methadone program: A longitudinal study.Journal of Opioid Management, 3(1), 27–34.
7.
EngdahlB., RomelsjöA., & SandM. (2006). Behandling av opiatmissbrukare i Sverige med Subutex 2000-2005: En studie av ändrad behandlingspolicy? (SoRAD Rapportserie, nr 35). Stockholm: Stockholms universitet, SoRAD.
8.
FischerB. (2000). Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada.Journal of Public Health Policy, 21, 187–210.
9.
FugelstadA., StenbackaM., LeifmanA., NylanderM., & ThiblinI. (2007). Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings.Addiction, 102(3), 406–412.
10.
GiacomuzziS., RiemerY., ErtlM., KemmlerG., RösslerH., HinterhuberH., & KurzM. (2005). Gender differences in health-related quality of life on admission to a maintenance treatment program.European Addiction Research, 11, 69–75. DOI: 10.1159/000083035
11.
GrönbladhL. (2004). A national Swedish methadone program 1966-1989.Diss. (sammanfattning). Uppsala: Uppsala universitet.
12.
GrönbladhL., ÖhlundL., & GunneL. (1990). Mortality in heroin addiction: Impact of methadone treatment.Acta Psychiatrica Scandinavica, 82, 223–227.
13.
GunneL., Grönbladh.L., & ÖhlundL. (2002). Treatment characteristics and retention in methadone maintenance: High and stable retention rates in a Swedish two-face programme.Heroin Addiction and Related Clinical Problems, 4, 37–45.
14.
HeiligM. (2003). Dum dogmatism dödar. Om substitutionsbehandling. I ThamH. (Red.), Forskare om narkotikapolitiken (Rapport 2003:1).Stockholm: Kriminologiska institutionen.
HortonM.Jr., (1993). Future directions in the development of addiction assessment instruments. In RounsavilleB. J., TimsF. M., HortonA. M.Jr., & SowderB. J. (Eds.), Diagnostic source book on drug abuse research and treatment (pp. 87–92). NIH Publication No. 93-3508, National Institute on Drug Abuse, Rockville, Maryland.
17.
HserY., AnglinM., & McGlothlinW., (1987). Sex differences in addict careers: 1. Initiation of use.American Journal of Drug and Alcohol Abuse, 13, 33–57.
18.
HserY. I., HuangD., TeruyaC., & Douglas AnglinM. (2003). Gender comparisons of drug abuse treatment outcomes and predictors.Drug and Alcohol Dependence, 72, 255–264.
19.
JohnsonB. (2003). Policyspridning som översättning: den politiska översättningen av metadonbehandling och husläkare i Sverige.Diss. Lund: Lund University.
20.
JohnsonB. (2005). Metadon på liv och död: en bok om narkomanvård och narkotikapolitik i Sverige.Lund: Studentlitteratur.
21.
JohnsonB. (2007): After the storm. Developments in maintenance treatment policy and practice in Sweden 1987-2006. In: Edman,J., & Stenius,K. (eds.): On the margins Nordic alcohol and drug treatment 1885- 2007. NAD Publication 50 (pp. 259–314). Helsingfors: Nordic Centre for Alcohol and Drug Research
22.
JohnsonB. (2010). Risker och sidoeffekter i läkemedelsassisterad rehabilitering opioidberoende - en forskningsöversikt.Socialvetenskaplig tidskrift, 1(1). Passim.
23.
KakkoJ., SvanborgK. D., KreekM. J., & HeiligM. (2003). 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial.Lancet, 22; 361(9358), 662–668.
24.
KakkoJ., GrönbladhL., Dybrandt SvanborgK., von WachenfeldtJ., RückC., RawlingsB., NilssonL.-H., & HeiligM. (2007). A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial.American Journal of Psychiatry, 164(5), 797–803.
25.
KarowA., VertheinU., PukropR., ReimerJ., HaasenC., KrauszM., & SchäferI. (2011). Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence.Substance Use & Misuse, 46, 705–715.
26.
LundgrenL., AmodeoM., FergusonF., & DavisK. (2001). Racial and ethnic differences in drug treatment entry by injection drug users in Massachusetts, 1996-1999.Journal of Substance Abuse Treatment, 21(3), 145–153.
27.
LundgrenL. M., SullivanL. M., MainaA. W., & SchillingR. F. (2007). Client factors associated with length of stay in methadone treatment among heroin users who inject drugs: Quantitative analysis of state-level substance abuse treatment utilization data.Journal of Addiction Medicine, 1(1), 26–32.
28.
McLellanA. T., CacciolaJ., KushnerH., PetersF., SmithI., & PettinatiH. (1992). The fifth edition of the Addiction Severity Index: Cautions, additions, and normative data.Journal of Substance Abuse Treatment, 5, 312–316.
NilssonI. (2011). Splittrad syn på Missbruksutredningens förslag.Alkohol & Narkotika, 6, 24–26.
31.
NosykB., GuhD., SunH., Oviedo-JoekesE., BrissetteS., MarshD., SchechterM., & AnisA. (2011). Health related quality of life trajectories of patients in opioid substitution treatment.Drug and Alcohol Dependence, 118(2-3), 259–264.
32.
PalmstiernaT. (Ed.). (2004). Behandling av personer med komplexa vårdbehov p. g. a. psykisk störning och missbruk.Fokusrapport. Stockholm: Stockholms läns landsting.
33.
PeterssonF. (2013). Kontroll av beroende: substitutionsbehandlingens logik, praktik och semantik.Diss. Göteborg: Göteborgs universitet.
34.
PowisB., GriffithsP., GossopM., & StrangJ. (1996). The differences between male and female drug users: Community samples of heroin and cocaine users compared.Substance use and Misuse, 31(5), 529–543.
35.
PuigdollersE., Domingo-SalvanyA., BrugalM., TorrensM., AlvarósJ., CastilloC., MagriN., MartinS., & VázquezJ. (2004). Characteristics of heroin addicts entering methadone maintenance treatment: Quality of life and gender.Substance Uuse and Misuse, 39(9), 1353–1368.
36.
RomelsjöA., EngdahlB.StenbackaM., FugelstadA., DavstadI., LeifmanA., & ThiblinI. (2010). Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?Addiction, 105, 1625–1632.
37.
SandM., & RomelsjöA. (2005). Opiatmissbrukare med och utan behandling i Stockholms län. (Rapport nr. 30). Stockholm: Stockholms universitet, SoRAD.
38.
SaumC. A., HillerM. L., LeigeyM. E., InciardiJ. A., & SurrattH. L. (2007). Predictors of substance abuse treatment entry for crime-involved, cocaine-dependent women.Drug and Alcohol Dependence, 91, 253–259.
39.
SkrettingA., & RosenqvistP. (2010). Shifting focus in substitution treatment in the Nordic countries.Nordic Studies on Alcohol and Drugs, 27(6), 581–597.
40.
Socialstyrelsen (SOSFS 1990:16): Socialstyrelsens föreskrifter om metadonunderhållsbehandling och förskrivning av opiater på indikation narkomani.Stockholm: Socialstyrelsen.
41.
Socialstyrelsen (2001). Långtidsuppföljning av patienter i metadonbehandling.Stockholm: Socialstyrelsen.
42.
Socialstyrelsen (2004). Läkemedelsassisterad underhållsbehandling av heroinmissbrukare - En kunskapsöversikt.Stockholm: Socialstyrelsen
43.
Socialstyrelsen (SOSFS 2004:8): Socialstyrelsens föreskrifter och all-männa råd om läkemedelsassisterad underhållsbehandling vid opiatberoende.Stockholm: Socialstyrelsen
44.
Socialstyrelsen (2006). Metadonregistret: registerbokslut - sammanställning av vissa uppgifter.Stockholm: Socialstyrelsen.
45.
Socialstyrelsen (2007). Läkemedelsassisterad underhållsbehandling vid opiatberoende - Rapport från en nationellt samordnad granskning.Stockholm: Socialstyrelsen.
46.
Socialstyrelsen (2012). Kartläggning av läkemedelsassisterad behandling vid opiatberoende.Stockholm: Socialstyrelsen.
47.
SOU 2011:35. Bättre insatser vid missbruk och beroende - Individen, kunskapen och ansvaret. Slutbetänkande av Missbruksutredningen.Stockholm: Fritzes.
48.
StenbackaM., & RomelsjöA. (1997). Metadonbehandling i Sverige.Stockholm, Socialstyrelsen.
49.
SteentoftA., TeigeB., HolmgrenP., VuoriE., KristinssonJ., HansenA. C., CederG., WetheG., RollmanD., & RollmannD. (2006). Fatal poisoning in Nordic drug addicts in 2002.Forensic Science International, 160(2-3), 148–156.
